However, OX40 was largely co-expressed with exhaustion marker PD1 on CD8+ T cells from HCV-related HCC patients, suggesting prior antigen specific activation and thus hinting to pre-existing in situ anti-tumour reactivity (124). The gene discussed is TNFRSF4; the disease is hepatocellular carcinoma.